
Sign up to save your podcasts
Or


Today we're sitting down with Dr. Steven Quay and talking all things breast cancer prevention! Dr. Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.
He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times.
He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.
His current passion is the prevention of the two million yearly breast cancer cases worldwide.
Dr. Quay's website
By Operation Podcast4.6
4646 ratings
Today we're sitting down with Dr. Steven Quay and talking all things breast cancer prevention! Dr. Quay is the founder of Seattle-based Atossa Therapeutics Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods for breast cancer and other breast conditions.
He received his M.D. and Ph.D. from The University of Michigan, was a postdoctoral fellow at MIT with Nobel Laureate H. Gobind Khorana, a resident at the Harvard-MGH Hospital, and was on the faculty of Stanford University School of Medicine. His contributions to medicine have been cited over 9,600 times.
He has founded six startups, invented seven FDA-approved pharmaceuticals, and holds 87 US patents. Over 80 million people have benefited from the medicines he invented.
His current passion is the prevention of the two million yearly breast cancer cases worldwide.
Dr. Quay's website

1,174 Listeners

981 Listeners

49 Listeners

602 Listeners

134 Listeners

123 Listeners

45 Listeners

271 Listeners

6 Listeners

781 Listeners

144 Listeners

8 Listeners

725 Listeners

72 Listeners

19 Listeners

3 Listeners

21 Listeners

37 Listeners

31 Listeners